Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 1—January 2014
Dispatch

Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1

Maria Santagati1, Teresa Spanu1, Marina Scillato, Rosaria Santangelo, Fabio Cavallaro, Vincenzo Arena, Giacomo Castiglione, Marco Falcone, Mario Venditti, and Stefania StefaniComments to Author 
Author affiliations: University of Catania, Catania, Italy (M. Santagati, M. Scillato, S. Stefani); Catholic University of the Sacred Heart, Rome, Italy (T. Spanu, R. Santangelo, F. Cavallaro, V. Arena); Vittorio Emanuele Hospital, Catania (G. Castiglione); University of Rome La Sapienza, Rome (M. Falcone, M. Venditti)

Main Article

Table

Primers used for identification of virulence genes by PCR for group C Streptococcus isolates*

Gene Primer name† Primer sequence, 5′→3′ Amplicon size, bp
Slo MS442 GGTAACCTTGTTACTGCTAATGCTGA 400
MS443 TAATGGAAATATCGACTGGTGTAGTG‡ 400
speA speA-fw CTCAACAAGACCCCGATCCAAG 500
speA-rew ATTTAGAAGGTCCATTAGTATATAGTTGC‡ 500
speB MS384 GGCATGTCCGCCTACTTTACCGA 800
MS385 CAGGTGCACGAAGCGCAGAAG‡ 800
speC MS410 TACTGATTTCTACTATTTCACCTATCATC 447
MS411 TCTGATTTTAAAGTCAATTTCCTGG‡ 447
speG MS412 GCTATGGAAGTCAATTAGCTTATGCAG 448
MS413 CCGATGTATAACGCGATTCCGA‡ 448
speI speI-up GGTCCGCCATTTTCAGGTAGTTT 516
speI-rew ACGCATACGAAATCATACCAGTAG‡ 516
speJ MS414 CACTCCTTGTACTAGATGAGGTTGC 508
MS415 ACGCATACGAAATCATACCAGTAG‡ 508
sagBC sagBC-fw GCAGCTAGTTGCTCAACATTTAATG 600
sagBC sagBC-rew CATAGGCAGTCGCCTGATTCC‡ 600
prtF MS400 CGGAGTATCAGTAGGACATGCGGA 882
prtF MS401 CTCCCACCAACATTGCTTAATCCA‡ 882
PAM PAM-fw GCAGACGACGCTAGAAATGAAGTA 900
PAM-rew CCTGCTTGTGGTGCTTGACCTTTAC‡ 900
Sof MS402 ATGCCTGGTTGGGTATCTTCGGT 406
MS403 AGAGAACAAAACGTTCTGCGCCTA‡ 406
Ssa ssa-fw GTAGTCAGCCTGACCCTACTCCAGAAC 621
ssa-rew ACTGATCAAATATTGCTGCAGGTGC‡ 621
sda1 MS431 GGGTCTATAAGAAAAGTGGGCAAAG 439
MS432 TGATCGTAAAGGTGGGATGCAGTA‡ 439

*slo, streptolysin O; sagA/BC, streptolysin S-associated gene A protein; smeZ-2 mitogenic exotoxin Z; speA, streptococcal pyrogenic toxin A; speB, streptococcal cysteine protease; speC, streptococcal pyrogenic toxin C; speG, streptococcal pyrogenic toxin G; speI, streptococcal pyrogenic toxin I; speJ; streptococcal pyrogenic toxin J; prtF, fibronectin-binding protein; PAM, plasminogen-binding protein; sof serum opacity factor; ssa streptococcal superantigen; sda1, streptodornase D.
†Primers indicated in boldface were created with the VectorNT program (Invitrogen, Carlsbad, CA, USA). Other primers were described by Santagati et al. (11).
‡Reverse primers.

Main Article

References
  1. Carapetis  JR, Steer  AC, Mulholland  EK, Weber  M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:68594. DOIPubMedGoogle Scholar
  2. Steer  AC, Lamagni  T, Curtis  N, Carapetis  JR. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012;72:121327. DOIPubMedGoogle Scholar
  3. Cole  JN, Barnett  TC, Nizet  V, Walker  MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol. 2011;9:72436. DOIPubMedGoogle Scholar
  4. Henningham  A, Barnett  TC, Maamary  PG, Walker  MJ. Pathogenesis of group A streptococcal infections. Discov Med. 2012;13:32942 .PubMedGoogle Scholar
  5. Friães  A, Pinto  FR, Silva-Costa  C, Ramirez  M, Melo-Cristino  J. Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol. 2012;12:280. DOIPubMedGoogle Scholar
  6. Lamagni  TL, Efstratiou  A, Vuopio-Varkila  J, Jasir  A, Schalén  C. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill. 2005;10:17984 .PubMedGoogle Scholar
  7. Turner  CE, Dryden  M, Holden  MT, Davies  FJ, Lawrenson  RA, Farzaneh  L, Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes. J Clin Microbiol. 2013;51:208995. DOIPubMedGoogle Scholar
  8. Sumby  P, Porcella  SF, Madrigal  AG, Barbian  KD, Virtaneva  K, Ricklefs  SM, Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005;192:77182. DOIPubMedGoogle Scholar
  9. Herwald  H, Cramer  H, Mörgelin  M, Russell  W, Sollenberg  U, Norrby-Teglund  A, M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell. 2004;116:36779. DOIPubMedGoogle Scholar
  10. Uchiyama  S, Andreoni  F, Schuepbach  RA, Nizet  V, Zinkernagel  AS. DNase Sda1 allows invasive M1T1 group A Streptococcus to prevent TLR9-dependent recognition. PLoS Pathog. 2012;8:e1002736. DOIPubMedGoogle Scholar
  11. Santagati  M, Scillato  M, Patane  F, Aiello  C, Stefani  S. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol. 2012;65:2331. DOIPubMedGoogle Scholar
  12. Lassalle  S, Hofman  V, Butori  C, Sicard  D, Hofman  P. Histological diagnosis of lung bacterial necrotizing infections: a study of four fulminant cases. Ann Pathol. 2005;25:34956. DOIPubMedGoogle Scholar
  13. Walker  MJ, Hollands  A, Sanderson-Smith  ML, Cole  JN, Kirk  JK, Henningham  A, DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med. 2007;13:9815. DOIPubMedGoogle Scholar
  14. Kansal  RG, McGeer  A, Low  DE, Norrby-Teglund  A, Kotb  M. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun. 2000;68:63629 . DOIPubMedGoogle Scholar

Main Article

1These authors contributed equally to this article.

Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external